Mr. Grassley voiced his concerns on what drugmakers could do to drug prices during future health crises if the bill he is sponsoring does not pass, calling the scenario “the Wild West.”
He released an analysis in March revealing the bill would save taxpayers $95 billion during the next decade.
Mr. Grassley reported that President Donald Trump supports the bill, an attitude that will be important, as Senate Majority Leader Mitch McConnell, R-Ky., has yet to agree fully with the legislation.
Senate Majority Whip John Thune, R-S.D., said Congress will more likely pass legislation focused on drug prices under Medicare Part D than the broader bill at hand, as he thinks Mr. Grassley’s bill will turn into an issue both parties use during the election season.
More articles on pharmacy:
5 recent CMS pharmacy policy changes
Eli Lilly testing COVID-19 drug derived from survivor blood
Researchers testing several heart, anti-platelet drugs for COVID-19 patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
